Join Daniel Hawkins, Avail CEO, and Jill Canada, Avail VP of Enterprise and Corporate Sales, for a session providing an update on telepresence and its adoption in MedTech across departments and functions. The session will be held on Wednesday, October 18 from 2:45-3:25 PM PDT in Room 210. Daniel and Jill will lead a discussion about starting telepresence programs and address other frequently asked questions.
Join Avail CEO Daniel Hawkins on Monday, October 9 from 1:45-2:15 PM PDT for the panel, “From Idea to Impact: Successful Product Commercialization for Startups and Established Companies.” The discussion will take place at Hall A, Booth 639 at the Anaheim Convention Center. Attendees will learn what it takes to successfully commercialize new technologies within companies of any size and stage.
An expanding customer base, rapidly advancing technology and intense cost pressures are driving medtech companies to use surgical telepresence to cost effectively meet customer needs, enhance customer relationships, develop new products faster and empower healthcare providers to raise the standard of care.